RPRX
NASDAQ · Pharmaceuticals
Royalty Pharma Plc- Cl A
$50.79
+0.59 (+1.18%)
Performance
1D
—
1W
—
1M
—
3M
+15.30%
6M
+30.36%
1Y
+52.29%
YTD
+30.70%
Open$50.78
Previous Close$50.20
Day High$51.17
Day Low$50.50
52W High$51.65
52W Low$32.15
Volume—
Avg Volume3.76M
Market Cap28.96B
P/E Ratio37.57
EPS$1.37
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$40.77
Above
SMA 200
$37.28
Above
RSI (14)
85.1
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
-28.6% upside
Current
$50.79
$50.79
Target
$36.26
$36.26
$26.65
$36.26 avg
$40.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.40B | 2.35B | 6.69B |
| Net Income | 778.89M | 686.86M | 946.13M |
| Profit Margin | 32.4% | 30.8% | 14.1% |
| EBITDA | 1.56B | 1.45B | 1.13B |
| Free Cash Flow | — | — | 700.09M |
| Rev Growth | +2.1% | +2.1% | +2.6% |
| Debt/Equity | 1.38 | 1.38 | 0.41 |
Dividend
Dividend Yield1.87%
Annual Dividend$0.65
Payout Ratio49.1%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |